308 related articles for article (PubMed ID: 30059711)
21. Two 6-(propan-2-yl)-4-methyl-morpholine-2,5-diones as new non-purine xanthine oxidase inhibitors and anti-inflammatory agents.
Smelcerovic A; Rangelov M; Smelcerovic Z; Veljkovic A; Cherneva E; Yancheva D; Nikolic GM; Petronijevic Z; Kocic G
Food Chem Toxicol; 2013 May; 55():493-7. PubMed ID: 23410588
[TBL] [Abstract][Full Text] [Related]
22. Lithospermic acid as a novel xanthine oxidase inhibitor has anti-inflammatory and hypouricemic effects in rats.
Liu X; Chen R; Shang Y; Jiao B; Huang C
Chem Biol Interact; 2008 Nov; 176(2-3):137-42. PubMed ID: 18694741
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, structure-activity relationships, and mechanistic studies of 5-arylazo-tropolone derivatives as novel xanthine oxidase (XO) inhibitors.
Sato D; Kisen T; Kumagai M; Ohta K
Bioorg Med Chem; 2018 Jan; 26(2):536-542. PubMed ID: 29274704
[TBL] [Abstract][Full Text] [Related]
24. Study on the interaction mechanism between luteoloside and xanthine oxidase by multi-spectroscopic and molecular docking methods.
Chen J; Wang Y; Pan X; Cheng Y; Liu J; Cao X
J Mol Recognit; 2022 Dec; 35(12):e2985. PubMed ID: 35907782
[TBL] [Abstract][Full Text] [Related]
25. Effects of Pimenta pseudocaryophyllus extracts on gout: Anti-inflammatory activity and anti-hyperuricemic effect through xantine oxidase and uricosuric action.
Ferrari FC; Lemos Lima Rde C; Schimith Ferraz Filha Z; Barros CH; de Paula Michel Araújo MC; Antunes Saúde-Guimarães D
J Ethnopharmacol; 2016 Mar; 180():37-42. PubMed ID: 26778678
[TBL] [Abstract][Full Text] [Related]
26. An oxidative coupling product of luteolin with cysteine ester and its enhanced inhibitory activity for xanthine oxidase.
Masuda T; Nojima S; Miura Y; Honda S; Masuda A
Bioorg Med Chem Lett; 2015 Aug; 25(16):3117-9. PubMed ID: 26096677
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic approach towards interaction of newly synthesized Hesperidin derivatives against xanthine oxidase.
Malik N; Dhiman P; Khatkar A
Int J Biol Macromol; 2019 Aug; 135():864-876. PubMed ID: 31163243
[TBL] [Abstract][Full Text] [Related]
28. Xanthine Oxidase Inhibitory and Molecular Docking Studies on Pyrimidones.
Zafar H; Iqbal S; Javaid S; Khan KM; Choudhary MI
Med Chem; 2018; 14(5):524-535. PubMed ID: 29189174
[TBL] [Abstract][Full Text] [Related]
29. Effects of extracts of leaves from Sparattosperma leucanthum on hyperuricemia and gouty arthritis.
Lemos Lima Rde C; Ferrari FC; de Souza MR; de Sá Pereira BM; de Paula CA; Saúde-Guimarães DA
J Ethnopharmacol; 2015 Feb; 161():194-9. PubMed ID: 25500302
[TBL] [Abstract][Full Text] [Related]
30. Anti-hyperuricemic and Anti-inflammatory Effects of
Rahmi EP; Kumolosasi E; Jalil J; Husain K; Buang F; Abd Razak AF; Jamal JA
Front Pharmacol; 2020; 11():289. PubMed ID: 32256360
[No Abstract] [Full Text] [Related]
31. Design, synthesis, and biological evaluation of N-(3-cyano-1H-indol-5/6-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamides and 5-(6-oxo-1,6-dihydropyrimidin-2-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Zhang B; Duan Y; Yang Y; Mao Q; Lin F; Gao J; Dai X; Zhang P; Li Q; Li J; Dai R; Wang S
Eur J Med Chem; 2022 Jan; 227():113928. PubMed ID: 34688012
[TBL] [Abstract][Full Text] [Related]
32. Xanthine oxidase inhibitory activity of nicotino/isonicotinohydrazides: A systematic approach from in vitro, in silico to in vivo studies.
Zafar H; Hayat M; Saied S; Khan M; Salar U; Malik R; Choudhary MI; Khan KM
Bioorg Med Chem; 2017 Apr; 25(8):2351-2371. PubMed ID: 28302506
[TBL] [Abstract][Full Text] [Related]
33. Computational Analysis and Synthesis of Syringic Acid Derivatives as Xanthine Oxidase Inhibitors.
Malik N; Khatkar A; Dhiman P
Med Chem; 2020; 16(5):643-653. PubMed ID: 31584375
[TBL] [Abstract][Full Text] [Related]
34. Biological interaction of newly synthesized astaxanthin-s-allyl cysteine biconjugate with Saccharomyces cerevisiae and mammalian α-glucosidase: In vitro kinetics and in silico docking analysis.
Sakayanathan P; Loganathan C; Iruthayaraj A; Periyasamy P; Poomani K; Periasamy V; Thayumanavan P
Int J Biol Macromol; 2018 Oct; 118(Pt A):252-262. PubMed ID: 29885400
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of pyrimidones and evaluation of their xanthine oxidase inhibitory and antioxidant activities.
Gurupadaswamy HD; Girish V; Zameer F; Hegdekatte R; Chauhan JB; Khanum SA
Arch Pharm (Weinheim); 2013 Nov; 346(11):805-11. PubMed ID: 24114987
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition.
Joshi G; Sharma M; Kalra S; Gavande NS; Singh S; Kumar R
Bioorg Chem; 2021 Feb; 107():104620. PubMed ID: 33454509
[TBL] [Abstract][Full Text] [Related]
37. Development of benzoxazole deoxybenzoin oxime and acyloxylamine derivatives targeting innate immune sensors and xanthine oxidase for treatment of gout.
Huang J; Zhou Z; Zhou M; Miao M; Li H; Hu Q
Bioorg Med Chem; 2018 May; 26(8):1653-1664. PubMed ID: 29472126
[TBL] [Abstract][Full Text] [Related]
38. An updated patent review: xanthine oxidase inhibitors for the treatment of hyperuricemia and gout (2011-2015).
Ojha R; Singh J; Ojha A; Singh H; Sharma S; Nepali K
Expert Opin Ther Pat; 2017 Mar; 27(3):311-345. PubMed ID: 27841045
[TBL] [Abstract][Full Text] [Related]
39. S-allyl cysteine alleviates nonsteroidal anti-inflammatory drug-induced gastric mucosal damages by increasing cyclooxygenase-2 inhibition, heme oxygenase-1 induction, and histone deacetylation inhibition.
Park JM; Han YM; Kangwan N; Lee SY; Jung MK; Kim EH; Hahm KB
J Gastroenterol Hepatol; 2014 Dec; 29 Suppl 4():80-92. PubMed ID: 25521739
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
